Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Mouse DDA3 gene is a direct transcriptional target of p53 and p73

Oncogene volume 21, pages 3050–3057 (2002)Cite this article

Abstract

The p53 tumor suppressor is a transcription factor that activates the expression of many target genes. We have previously reported the identification of a p53-regulated mouse gene DDA3. The 5′ upstream genomic region of the mouse DDA3 was cloned, and sequence analysis revealed the presence of a potential p53 response element (RE2) residing at nucleotides +390∼+409 relative to the first translation start site. When fused upstream to a luciferase reporter gene, 5′ genomic regions of the DDA3 gene containing RE2 were shown to be responsive to the wild-type, but not mutant p53, in a transient transfection assay. RE2 was sufficient to confer the transactivation responsiveness to p53. Furthermore, gel mobility shift analysis showed that RE2 formed specific complexes with wild-type p53. Induction of DDA3 was found in adriamycin treated normal mouse embryonic fibroblast cells (MEF), but not in p53 knockout (p53−/−) MEF. Overexpression of p73 induced DDA3 mRNA expression, and luciferase reporter analysis indicated that RE2 was responsive to transactivation by members of the p73 family proteins. Consistent with these findings, elevated expression of p73 protein and DDA3 mRNA were observed concomitantly in the p53−/− MEF cells treated with cisplatin. These results together demonstrated that DDA3 is a transcriptional target gene of p53 and its related-protein p73.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Agami R, Blandino G, Oren M, Shaul Y . 1999 Nature 399: 809–813

  • Agarwal ML, Agarwal A, Taylor WR, Stark GR . 1995 Proc. Natl. Acad. Sci. USA 92: 8493–8497

  • Aloni-Grinstein R, Schwartz D, Rotter V . 1995 EMBO J. 14: 1392–1401

  • Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ . 1995 Science 267: 1353–1356

  • De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annicchiarico-Petruzzelli M, Levrero M, Melino G . 1998 J. Exp. Med. 188: 1763–1768

  • Deng C, Zhang P, Harper JW, Elledge SJ, Leder P . 1995 Cell 82: 675–684

  • Di Como CJ, Gaiddon C, Prives C . 1999 Mol. Cell. Biol. 19: 1438–1449

  • El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B . 1992 Nat. Genet. 1: 45–49

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825

  • Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C . 1992 Nature 358: 83–86

  • Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin Jr WG, Levrero M, Wang JY . 1999 Nature 399: 806–809

  • Graeber TG, Peterson JF, Tsai M, Monica K, Fornace Jr AJ, Giaccia AJ . 1994 Mol. Cell Biol. 14: 6264–6277

  • Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . 1993 Cell 75: 805–816

  • Harris CC . 1993 Science 262: 1980–1981

  • Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B . 1997 Mol. Cell 1: 3–11

  • Hollstein M, Sidransky D, Vogelstein B, Harris CC . 1991 Science 253: 49–53

  • Irwin MS, Kaelin Jr WG . 2001 Apoptosis 6: 17–29

  • Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D . 1997 Cell 90: 809–819

  • Lane DP . 1992 Nature 358: 15–16

  • Lee CW, La Thangue NB . 1999 Oncogene 18: 4171–4181

  • Levine AJ . 1997 Cell 88: 323–331

  • Levine AJ, Momand J, Finlay CA . 1991 Nature 351: 453–456

  • Li R, Waga S, Hannon GJ, Beach D, Stillman B . 1994 Nature 371: 534–537

  • Linke SP, Clarkin KC, Di Leonardo A, Tsou A, Wahl GM . 1996 Genes Dev. 10: 934–947

  • Lo PK, Chen JY, Lo WC, Chen BF, Hsin JP, Tang PP, Wang FF . 1999 Oncogene 18: 7765–7774

  • Lohrum MA, Vousden KH . 2000 Trends Cell Biol. 10: 197–202

  • Marin MC, Kaelin Jr WG . 2000 Biochim. Biophys. Acta. 1470: M93–M100

  • McLure KG, Lee PW . 1998 EMBO J. 17: 3342–3350

  • Miyashita T, Reed JC . 1995 Cell 80: 293–299

  • Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N . 2000a Science 288: 1053–1058

  • Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y . 2000b Cell 102: 849–862

  • Ohki R, Nemoto J, Murasawa H, Oda E, Inazawa J, Tanaka N, Taniguchi T . 2000 J. Biol. Chem. 275: 22627–22630

  • Oren M . 1994 Semin. Cancer Biol. 5: 221–227

  • Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C, Puisieux A . 1996 Nat. Genet. 14: 482–486

  • Ryan KM, Phillips AC, Vousden KH . 2001 Curr. Opin. Cell Biol. 13: 332–337

  • Schmale H, Bamberger C . 1997 Oncogene 15: 1363–1367

  • Stewart N, Hicks GG, Paraskevas F, Mowat M . 1995 Oncogene 10: 109–115

  • Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mark TW, Taniguchi T . 1994 Cell 77: 829–839

  • Tang PP, Wang FF . 2000 Leukemia 14: 1292–1300

  • Trink B, Okami K, Wu L, Sriuranpong V, Jen J, Sidransky D . 1998 Nat. Med. 4: 747–748

  • Utrera R, Collavin L, Lazarevic D, Delia D, Schneider C . 1998 EMBO J. 17: 5015–5025

  • Vogelstein B, Lane D, Levine AJ . 2000 Nature 408: 307–310

  • Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F . 1998 Mol. Cell 2: 305–316

  • Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B . 2001 Mol. Cell 7: 673–682

  • Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, Lu H, Kharbanda S, Weichselbaum R, Kufe D . 1999 Nature 399: 814–817

  • Zhu J, Chen X . 2000 Mol. Cell. Biol. 20: 5602–5618

  • Zhu J, Jiang J, Zhou W, Chen X . 1998 Cancer Res. 58: 5061–5065

Download references

Acknowledgements

We thank Dr G Melino (University of Rome, Italy) for kindly providing us with the expression plasmids for p73α, β, γ, and δ; and Dr J Lin (University of Michigan, USA) for vectors expressing wild-type p53 and the transactivation defective p53R175H. This work was supported by Grants NSC89-2318-B010-010-M15 and NSC-91-2318-B010-003-M51 from the National Science Council, Taiwan, Republic of China.

Author information

Authors and Affiliations

  1. Institute of Biochemistry, National Yang-Ming University, Taipei, Taiwan 112, Republic of China

    Shu-Chen Hsieh, Pang-Kuo Lo & Fung-Fang Wang

Authors
  1. Shu-Chen Hsieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pang-Kuo Lo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fung-Fang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fung-Fang Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hsieh, SC., Lo, PK. & Wang, FF. Mouse DDA3 gene is a direct transcriptional target of p53 and p73. Oncogene 21, 3050–3057 (2002). https://doi.org/10.1038/sj.onc.1205417

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205417

Keywords

This article is cited by

Search

Advanced search

Quick links